Thymosin alpha-1 and vaccine response: does it mean fewer infections?
Antibody findings in vaccine trials are useful, but they do not establish general infection prevention. Explore the human studies and their practical limits.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
Antibody findings in vaccine trials are useful, but they do not establish general infection prevention. Explore the human studies and their practical limits.
Read articleWhat ARA-290 trials monitored, which serious events were reported, and why short studies cannot settle uncommon or longer-term risks.
Read articleSmall comparative studies exist, but they do not establish class-wide equivalence. Understand the medazepam, phenazepam and add-on evidence.
Read articleShort symptom reports cannot prove long-term freedom from dependence. Separate tolerance, physical dependence, addiction and symptoms after stopping.
Read articleCell counts, surface proteins and thymic-output markers can reveal biological activity. Learn why clinical outcomes still need their own evidence.
Read articleRetatrutide sharply reduced MRI-measured liver fat in a small substudy. That result differs from proving MASH resolution, fibrosis improvement or fewer liver complications.
Read articleBPC-157 changes vessel behavior in laboratory studies. Learn why that raises specific research questions without settling long-term human cancer safety.
Read articleHumanin can support cell survival, but experimental tumor studies show why that effect needs cancer-specific scrutiny.
Read articleFeline exenatide studies show how species, disease stage, background care and measured outcomes determine what pet peptide research can actually tell owners.
Read articleHuman studies show that kisspeptin can stimulate LH and testosterone. The clinical question is whether those signals lead to sustained, meaningful benefits.
Read articleOlder hepatitis studies tested specific viral and liver outcomes. Understand delayed responses, mixed results and the relevance to today's antiviral care.
Read articleA purity percentage answers only part of the product-quality question. Learn how identity, amount, microbial testing, and sample traceability differ.
Read article145–156 of 323 articles